Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02261805
Title A Phase I/II Study of Ganetespib in Combination With Doxorubicin
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Georgetown University

lung small cell carcinoma


Aldoxorubicin + Ganetespib

Age Groups: adult
Covered Countries USA

No variant requirements are available.